@[Ketan Desai](user:4649), I think it's rare for authors to cover a stock with a completely unbiased view. Most write about a company because they feel strongly one way or the other.
Personally, I feel it's the reader's obligation to do some due diligence and seek out differing opinions and then make an informed decision on whether to invest. That's one of the reasons I love this site - I can read what different intelligent contributors have to say about the same stock. Unfortunately, there isn't much coverage on $CYDY. I think it would be great if you wrote an article about this stock as well so we could see some differing opinions. If you add up all your comments, the article is practically already written!
CytoDyn Investors Sell Despite Positive Recommendation From DSMB And A More Certain Path To COVID-19 Approval
Appreciate your putting $CYDY on my radar. Been following it since you first started writing about them.
CytoDyn Investors Sell Despite Positive Recommendation From DSMB And A More Certain Path To COVID-19 Approval
Good to know on $CYDY.
CytoDyn’s Data: Approvable Drug Sets Stage For Near-Term Move Upward
Perhaps I should have listened to you and stuck to forex which I know. $CYDY is down quite a bit since I first read this.
CytoDyn's Update Provides A Clear Path Towards Approval With Up-Listing Potential Still In The Cards
It's very hard to know who/what to believe about $CYDY. There seems to be so much conflicting info.
CytoDyn's Update Provides A Clear Path Towards Approval With Up-Listing Potential Still In The Cards
Good article, but my enthusiasm for $CYDY has really waned after reading some of @[Ketan Desai](user:4649)'s comments.
CytoDyn’s Data: Approvable Drug Sets Stage For Near-Term Move Upward
When will your next article on $CYDY be out?
CytoDyn’s Data: Approvable Drug Sets Stage For Near-Term Move Upward
@[Ketan Desai](user:4649), I think it's rare for authors to cover a stock with a completely unbiased view. Most write about a company because they feel strongly one way or the other.
Personally, I feel it's the reader's obligation to do some due diligence and seek out differing opinions and then make an informed decision on whether to invest. That's one of the reasons I love this site - I can read what different intelligent contributors have to say about the same stock. Unfortunately, there isn't much coverage on $CYDY. I think it would be great if you wrote an article about this stock as well so we could see some differing opinions. If you add up all your comments, the article is practically already written!
HIV Cure Challenger CytoDyn Takes On Gilead Sciences
Is that Charlie Sheen in the video? Had no idea he had HIV. That's a pretty big endorsement he's giving $CYDY
CytoDyn’s Data: Approvable Drug Sets Stage For Near-Term Move Upward
@[Chuckles 759](user:135315) and @[Chump Punk](user:135341), what's your take on this $CYDY update?
CytoDyn’s Data: Approvable Drug Sets Stage For Near-Term Move Upward
Thanks for replying, not all authors are considerate enough to do so. I'll be adding $CYDY to my watchlist.